skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The potential effects of DPP‐4 inhibitors on cardiovascular system in COVID‐19 patients
Material Type:
Article
Add to My Research

The potential effects of DPP‐4 inhibitors on cardiovascular system in COVID‐19 patients

Journal of Cellular and Molecular Medicine, 2020-09, Vol.24 (18), p.10274-10278 [Peer Reviewed Journal]

2020 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd ;2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.15674 ;PMID: 32713161

Digital Resources/Online E-Resources

2
Mortality and pre‐hospitalization use of low‐dose aspirin in COVID‐19 patients with coronary artery disease
Material Type:
Article
Add to My Research

Mortality and pre‐hospitalization use of low‐dose aspirin in COVID‐19 patients with coronary artery disease

Journal of Cellular and Molecular Medicine, 2021-01, Vol.25 (2), p.1263-1273 [Peer Reviewed Journal]

2020 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.16198 ;PMID: 33336936

Digital Resources/Online E-Resources

3
Association of glycosylated haemoglobin HbA1c levels with outcome in patients with COVID‐19: A Retrospective Study
Material Type:
Article
Add to My Research

Association of glycosylated haemoglobin HbA1c levels with outcome in patients with COVID‐19: A Retrospective Study

Journal of cellular and molecular medicine, 2021-04, Vol.25 (7), p.3484-3497 [Peer Reviewed Journal]

2021 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;COPYRIGHT 2021 Wiley Subscription Services, Inc. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.16431 ;PMID: 33694276

Full text available

4
MiR‐320a contributes to atherogenesis by augmenting multiple risk factors and down‐regulating SRF
Material Type:
Article
Add to My Research

MiR‐320a contributes to atherogenesis by augmenting multiple risk factors and down‐regulating SRF

Journal of cellular and molecular medicine, 2015-05, Vol.19 (5), p.970-985 [Peer Reviewed Journal]

2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;Copyright © 2015 Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine ;2015. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. 2015 ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.12483 ;PMID: 25728840

Full text available

5
A common variant of RIP3 promoter region is associated with poor prognosis in heart failure patients by influencing SOX17 binding
Material Type:
Article
Add to My Research

A common variant of RIP3 promoter region is associated with poor prognosis in heart failure patients by influencing SOX17 binding

Journal of cellular and molecular medicine, 2019-08, Vol.23 (8), p.5317-5328 [Peer Reviewed Journal]

2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14408 ;PMID: 31148336

Full text available

6
Genetic risk scores to predict the prognosis of chronic heart failure patients in Chinese Han
Material Type:
Article
Add to My Research

Genetic risk scores to predict the prognosis of chronic heart failure patients in Chinese Han

Journal of cellular and molecular medicine, 2020-01, Vol.24 (1), p.285-293 [Peer Reviewed Journal]

2019 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2019 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14722 ;PMID: 31670483

Full text available

7
miR‐1322 regulates Ch REBP expression via binding a 3′‐ UTR variant (rs1051943)
Material Type:
Article
Add to My Research

miR‐1322 regulates Ch REBP expression via binding a 3′‐ UTR variant (rs1051943)

Journal of cellular and molecular medicine, 2018-11, Vol.22 (11), p.5322-5332 [Peer Reviewed Journal]

2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.13805

Full text available

8
miR‐1322 regulates ChREBP expression via binding a 3′‐UTR variant (rs1051943)
Material Type:
Article
Add to My Research

miR‐1322 regulates ChREBP expression via binding a 3′‐UTR variant (rs1051943)

Journal of cellular and molecular medicine, 2018-11, Vol.22 (11), p.5322-5332 [Peer Reviewed Journal]

2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.13805 ;PMID: 30079502

Full text available

Searching Remote Databases, Please Wait